SCHEMBL13870908

SCHEMBL13870908

Cc1cc(C)c(-c2ccc3cc(C)c(C)cc3n2)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.43
AR P10275 6/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 2/20 0.37
PDGFRB P09619 1/20 0.37
KDR P35968 1/20 0.37
FLT3 P36888 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK10 P53779 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
KDM4E B2RXH2 3/20 0.35
CYP1A2 P05177 2/20 0.35
ADORA3 P0DMS8 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870958 0.85 NQO2 (0.35) NQO2ARNPC1RAB9APDGFRB
SCHEMBL13989400 0.85 CYP1A2 (0.52) NQO2ARMAPTALDH1A1KMT2A
SCHEMBL13870938 0.84 NQO2 (0.46) NQO2NPC1RAB9APDGFRBSMN1; SMN2
SCHEMBL13870906 0.83 CYP1A2 (0.41) ARNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL13870905 0.83 CYP1A2 (0.41) ARRAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL13298974 0.83 CYP1A2 (0.53) NQO2ARNPC1RAB9ASMN1; SMN2
SCHEMBL13870902 0.78 NUDT1 (0.44) NQO2ARNPC1RAB9APDGFRB
SCHEMBL13870918 0.78 NQO2 (0.38) NQO2ARNPC1RAB9APDGFRB
SCHEMBL14500747 0.78 NCF1 (0.53) NQO2NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL16487809 0.77 TAAR1 (0.36) NQO2NPC1RAB9APDGFRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 NQO2 1945/4885AR 1429/4885NPC1 2112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.